icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
 
 
 
Safety and tolerability of extended (96 weeks) treatment with peginterferon alfa-2a [40KD] in genotype D patients with HBeAg-negative chronic hepatitis B
 
 
  Reported by Jules Levin
61st AASLD Nov 2 2010 Boston
 
P Lampertico, M Vigano, GG Di Costanzo, E Sagnelli, M Fasano, V Di Marco, S Boninsegna, P Farci, S Fargion, T Giuberti, C Iannacone, B Massetto, EB Martins, M Colombo on behalf of the PegBeLiver Study Group First Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UniversitÓ degli Studi di Milano, Milan, Italy